Pharmaceutical Discovery and Preclinical Development1

Β View Only
Back to discussions
Expand all | Collapse all

πŸ“’Β Call for Authors – Contribute to the AAPS PDPD Community Projects!

  • 1.  πŸ“’Β Call for Authors – Contribute to the AAPS PDPD Community Projects!

    Community Leadership
    Posted 05-28-2025 09:40

    πŸ“’ Call for Authors – Contribute to the AAPS PDPD Community Projects!

    Are you working on cutting-edge topics in pharmaceutical discovery or preclinical development? Want to showcase your expertise or share key insights with the broader scientific community?

    The AAPS Pharmaceutical Discovery & Preclinical Development (PDPD) Community is currently seeking contributors for upcoming news articles, webinars and short courses!

    We are especially looking for authors to write on timely and exciting topics such as:

    πŸ”Ή Bioavailability of PROTACs
    πŸ”Ή Drug Repurposing for Rare Diseases
    πŸ”Ή AI in Biotechnology and Drug Discovery

    πŸ§ͺ What We're Looking For:
    Members who share research updates, literature highlights, expert opinions, or relevant case studies.

    πŸ‘©β€πŸ”¬ Who Can Submit?
    All AAPS PDPD members - students, early-career professionals, academics, and industry scientists - are welcome to contribute.

    πŸ“§ Interested in Writing?
    Reach out to us at [email protected],  [email protected] or  [email protected] with your topic of interest, or area of interest, with a brief introduction on your experience with the topic. You can also respond to this post and connect with us on the AAPS PDPD Community page.

    Contribute your voice and help advance conversations that matter in pharma R&D!



    ------------------------------
    Dedeepya Pasupuleti, Ph.D.
    Mercer University
    Atlanta GA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------


  • 2.  RE: πŸ“’Β Call for Authors – Contribute to the AAPS PDPD Community Projects!

    Posted 05-29-2025 13:54
    Hi Dedeepya and Team,
    I am interested in contributing to this topic, "Drug Repurposing for Rare Diseases". Looking forward to more details.

    Kind regards,
    Swetha



    Original Message


  • 3.  RE: πŸ“’Β Call for Authors – Contribute to the AAPS PDPD Community Projects!

    Posted 06-11-2025 10:48
    Hello Dr. Das and Mrs. Dedeepva,
    I hope this email finds you well. I am following up on the previous email I sent a week ago about my interest in contributing to the Call for Authors – AAPS PDPD Community Projects. Could you kindly share the update, if any, at your earliest convenience? 

    Looking forward to hearing from you.

    Kind regards,
    Swetha Thiyagarajan




    On Mon, Jun 2, 2025 at 3:19β€―PM Swetha Thiyagarajan <[email protected]> wrote:
    Hello  Dr. Sudip Das
    Thanks for your email. Sounds good.
    I have access to my personal oneDrive, is that the one you are referring to?
    Kind regards,
    Swetha Thiyagarajan



    On Fri, May 30, 2025 at 7:19β€―AM Sudip Das <[email protected]> wrote:

    Hi Swetha,

    Thanks for your reply. I am taking the lead on drug repurposing and will share the articles that I have collected and schedule a meeting soon. Do you have access to OneDrive?

    Best -

     

    *********************************************

    Sudip Das, MPharm, PhD

    Distinguished Faculty

    Professor of Pharmaceutics & Drug Delivery, Butler University

    4600 Sunset Avenue, Indianapolis, IN 46208-3485

    E-mail:           [email protected]

    Webpage:         https://research.butler.edu/nanomedicine/

    LinkedIn:         http://www.linkedin.com/in/sudipkdas

    Citations:         Google scholar

    Pronouns:         He/Him

    E-Mail Privacy: This communication may contain confidential information and is intended solely for the use of the addressee.

    If you received it in error, please contact the sender at once and delete the message.

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.

     




    Original Message